What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“CaNCURE has helped to firm my interest in cancer medicine because it taught me the actual science behind a disease that presents itself in so many different ways. I love interacting with the cancer patients in our clinic because they are so humble and really teach me about taking life one day at a time.”

Marisa Wozniak, CaNCURE ’16


Trainee Spotlight


Kevin Lin

Health Science, '21

Granzyme B Peptide as a Non-invasive Theranostic Agent

Mia Wallach

Business (w Concentration in Healthcare Management and Consulting), '23

Nano-Talazoparib and Nano-Dinaciclib Combination Therapy for Lung Cancer Cells

Claire Buxton

Molecular Biology, '21

Role of ESRP1/ESRP2 splicing regulators in the development of Triple-Negative Breast Cancer

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


Cesar Martin Castro, M.D.

Instructor in Medicine, MGH

Our research seeks to bridge current needs in clinical oncology with novel nanosensing technologies to selectively detect and profile cancer cells and tissues. Students will examine the feasibility of using magneto-DNA nanoparticles to characterize rare cancer cells in unpurified human clinical samples including ascites and blood.


G Mike Makrigiorgos, Ph.D.

Professor of Radiation Oncology, HMS

We apply nanoparticle-based approaches for DNA molecular diagnostics, PCR-based detection of DNA alterations, as well as the enrichment and identification of cancer biomarkers from blood-circulating DNA/RNA. We also combine site-specific image-guided irradiation with nanoparticle based approaches for enhancing detection of circulating biomarkers via ‘liquid biopsy’.


Trainee Spotlight


Muskaan Rastogi

Health Science, '21

Monocyte Subtype Determination by Labeling with Feraheme Nanoparticles

Mahimasri Kotamreddy

Biology and Mathematics, '21

Understanding the Role of Epigenetics in Multiple Myeloma Progression

Claire Buxton

Molecular Biology, '21

Role of ESRP1/ESRP2 splicing regulators in the development of Triple-Negative Breast Cancer


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...